Factors affecting the neonatal response to artificial surfactant

Journal of Paediatrics and Child Health

Volumn 32, Issue 3, 1996, Pages 236-241

  Skelton, R ^a   Jeffery, H E ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

artificial surfactant; Exosurf; oxygenation index; respiratory distress syndrome; ventilatory response

Indexed keywords

LUNG SURFACTANT;

AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD OXYGENATION; DRUG RESPONSE; GESTATIONAL AGE; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN HYPOXIA; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; RELAPSE; RESPIRATORY DISTRESS SYNDROME;

EID: 0030055329     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb01561.x     Document Type: Article

References (34)

1. Avery ME, Merritt TA. Surfactant-replacement therapy. Editorial. N. Engl. J. Med. 1991; 324: 911-12.
2. Soll RF, McQueen MC. Respiratory distress syndrome. In Sinclair JC, Bracken MB, (eds.) Effective Care of the Newborn Infant. Oxford University Press, Oxford. 1992; 325-58.
3. Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem. Physics Lipids 1988; 49: 49-55.
4. Phibbs RH, Ballard RA, Clements JA et al. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 1991; 88: 1-9.
5. Dunn MS, Shennan AT, Possmayer F. Single versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks gestation with respiratory distress syndrome. Pediatrics 1990; 86: 564-71.
6. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics 1985; 76: 145-53.
7. Horbar JD, Soll RF, James MD et al. A multicenter randomised, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N. Engl. J. Med. 1989; 320: 959-65.
8. Merritt TA, Hallman M, Berry C et al. Randomised, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. Fetal Neonatal Med. 1991; 118: 581-95.
9. Hallman M, Merritt A, Jarvenpaa AL et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomised prospective clinical trial. J. Pediatr. 1985; 106: 963-9.
10. Fujiwara T, Konishi M, Chida S et al. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: Final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. Pediatrics 1990; 86: 753-64.
11. Fujiwara T, Konishi M, Chida S, Maeta H. Factors affecting the response to a postnatal single dose of a reconstituted bovine surfactant (Surfactant TA). In Lachmann B, ed. Surfactant Replacement Therapy in Neonatal and Adult Respiratory Distress Syndrome. Springer-Verlag, Berlin-Heidelberg, 1987; 91-107.
12. Charon A, Taeusch W, Fitzgibbon C, Smith GB, Treves ST, Phelps DS. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics 1989; 83: 348-54.
13. Segerer H, Stevens P, Schadow B et al. Surfactant substitution in ventilated very low birth weight infants: factors related to response types. Pediatr. Res. 1991; 30: 591-6.
14. Mallman M, Pohjavuori M, Jarvenpaa AL, Bry K, Merritt TA, Pesonen E. Human surfactant in the treatment of respiratory distress syndrome A spectrum of clinical responses. Eur. Resp. J. 1989; 2: S77-80.
15. Wallenbrock MA, Sekar KC, Toubas PL. Prediction of the acute response to surfactant therapy by pulmonary function testing. Pediatr. Pulmonol. 1992; 13: 11-15.
16. Gitlin JD, Soll RF, Parad RB et al. Randomised controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 1987; 79: 31-7.
17. Kendig JW, Notter RH, Cox C et al. Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 1988; 82: 756-62.
18. Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: A randomised controlled trial of prophylaxis versus treatment. Pediatrics 1991; 87: 377-86.
19. Evans NH. Diagnosis of patent ductus arteriosus in the preterm newborn. Arch. Dis. Child. 1993; 68: 58-61.
20. Gilbert R, Keighley JF. The arterial/alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am. Rev. Resp. Dis. 1974; 109: 142-5.
21. SPSS/PC + Version 4.0: Statistical package for the social sciences (computer program). SPSS Inc, Chicago, IL, USA.
22. Milner AD. How does exogenous surfactant work? Arch. Dis. Child. 1993; 68: 253-4.
23. Segerer H, Van Gelder W, Angerent FWM et al. Pulmonary distribution and efficacy of exogenous surfactant in lung lavaged rabbits is influenced by the instillation technique. Pediatr. Res. 1993; 34: 490-4.
24. Ueda T, Ikegami M, Rider ED, Jobe AH. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J. Appl. Physiol. 1994; 1: 45-55.
25. Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J. Paediatr. Child Health 1994; 30: 406-11.
26. Ashbaugh DG, Bigelow DB, Petty TL et al. Acute respiratory distress in adults. Lancet 1967; 2: 319.
27. Sarniak AP, Lieh L. Adult respiratory distress syndrome in children. Pediatr. Clinic 1994; 41: 337-61.
28. Seeger W, Gruber C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur. Resp. J. 1993; 6: 971-7.
29. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J. Appl. Physiol. 1987; 62: 429-37.
30. Berry D, Ikegami M, Jobe A. Respiratory distress and surfactant inhibition following vagotomy in rabbits. J. Appl. Physiol. 1986; 61: 1741-48.
31. Bui KC, Walther FJ, Remedios DC, Garg M, Warburton D. Phospholipid and surfactant protein A concentration in tracheal aspirates from infants requiring ECMO. J. Pediatr. 1992; 121: 271-4.
32. Auten RL, Notter RH, Kendig JW, Shapiro DL. Surfactant teatment of fullterm newborns with respiratory failure. Pediatrics 1991; 87: 101-7.
33. Skelton R, Jeffery HE. 'Click test': Rapid diagnosis of the respiratory distress syndrome. Pediatr. Pulmonol. 1994; 17: 383-9.
34. OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS. Lancet 1992; 340: 1363-9.